BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15598681)

  • 1. Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation.
    Kim KY; Choi KC; Park SH; Auersperg N; Leung PC
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1670-7. PubMed ID: 15598681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells.
    Kim KY; Choi KC; Park SH; Chou CS; Auersperg N; Leung PC
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3020-6. PubMed ID: 15181093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway.
    Kim KY; Choi KC; Auersperg N; Leung PC
    Endocr Relat Cancer; 2006 Mar; 13(1):211-20. PubMed ID: 16601289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
    Kraus S; Levy G; Hanoch T; Naor Z; Seger R
    Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
    Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
    Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
    Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
    Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42.
    Levi NL; Hanoch T; Benard O; Rozenblat M; Harris D; Reiss N; Naor Z; Seger R
    Mol Endocrinol; 1998 Jun; 12(6):815-24. PubMed ID: 9626657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
    Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter.
    Bonfil D; Chuderland D; Kraus S; Shahbazian D; Friedberg I; Seger R; Naor Z
    Endocrinology; 2004 May; 145(5):2228-44. PubMed ID: 14736735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
    Mhaidat NM; Zhang XD; Jiang CC; Hersey P
    Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the p38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone.
    Roberson MS; Zhang T; Li HL; Mulvaney JM
    Endocrinology; 1999 Mar; 140(3):1310-8. PubMed ID: 10067858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH activates ERK1/2 leading to the induction of c-fos and LHbeta protein expression in LbetaT2 cells.
    Liu F; Austin DA; Mellon PL; Olefsky JM; Webster NJ
    Mol Endocrinol; 2002 Mar; 16(3):419-34. PubMed ID: 11875099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular signal-regulated kinase and c-Src, but not Jun N-terminal kinase, are involved in basal and gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone alpha-subunit promoter.
    Harris D; Chuderland D; Bonfil D; Kraus S; Seger R; Naor Z
    Endocrinology; 2003 Feb; 144(2):612-22. PubMed ID: 12538624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
    Gründker C; Emons G
    Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.
    Park DW; Choi KC; MacCalman CD; Leung PC
    Reprod Biol Endocrinol; 2009 Aug; 7():81. PubMed ID: 19656390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.
    Andrade AA; Silva PN; Pereira AC; De Sousa LP; Ferreira PC; Gazzinelli RT; Kroon EG; Ropert C; Bonjardim CA
    Biochem J; 2004 Jul; 381(Pt 2):437-46. PubMed ID: 15025565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.